AbstractThe number of allogeneic hematopoietic stem cell (HSC) transplants performed globally each year continues to increase. Advances in HLA typing, better supportive care, and administration of reduced-intensity conditioning regimens allow treatment of older patients with older sibling donors. Pretransplant donor assessment and testing are very important processes affecting the quality and safety of donation. For unrelated HSC donors detailed recommendations for health assessment have been published, allowing donation only if they are unrestrictedly healthy. Eligibility criteria for related donors are less strict and vary significantly between centers. In situations where a family donor does not meet the suitability criteria for unrelate...
The increasing number of older adults with blood-related disorders and the introduction of reduced i...
We investigated whether a young human leukocyte antigen (HLA)-matched unrelated donor (MUD) should b...
Eligibility criteria for hematopoietic stem cell transplantation (HSCT) in acute lymphoblastic leuke...
AbstractThe number of allogeneic hematopoietic stem cell (HSC) transplants performed globally each y...
The number of allogeneic hematopoietic stem cell (HSC) transplants performed globally each year cont...
The contribution of related donors to the globally rising number of allogeneic haematopoietic stem c...
AbstractRelated donors for hematopoietic cell (HC) transplantation are a growing population in recen...
AbstractThe Blood and Marrow Transplant Clinical Trials Network (BMT CTN) conducts large, multi-inst...
AbstractWorldwide >10 million adults and 250 000 cord blood units are available for unrelated HCT. H...
Allogenic hematopoietic progenitor cell transplantation (allo-HSCT) is an established treatment for ...
Through the recruitment of immunologic mechanisms, allogeneic hematopoeitic cell transplantation (HC...
Allogenic haematopoietic progenitor cell transplantation (allo-HSCT) is an established treatment for...
Recent investigations have found a higher incidence of adverse events associated with hematopoietic ...
The studies described in this thesis are aimed at improving the whole spectrum of unrelated HSCT in ...
Hematopoietic cell transplantation (HCT) is a highly complex procedure that requires a dedicated mul...
The increasing number of older adults with blood-related disorders and the introduction of reduced i...
We investigated whether a young human leukocyte antigen (HLA)-matched unrelated donor (MUD) should b...
Eligibility criteria for hematopoietic stem cell transplantation (HSCT) in acute lymphoblastic leuke...
AbstractThe number of allogeneic hematopoietic stem cell (HSC) transplants performed globally each y...
The number of allogeneic hematopoietic stem cell (HSC) transplants performed globally each year cont...
The contribution of related donors to the globally rising number of allogeneic haematopoietic stem c...
AbstractRelated donors for hematopoietic cell (HC) transplantation are a growing population in recen...
AbstractThe Blood and Marrow Transplant Clinical Trials Network (BMT CTN) conducts large, multi-inst...
AbstractWorldwide >10 million adults and 250 000 cord blood units are available for unrelated HCT. H...
Allogenic hematopoietic progenitor cell transplantation (allo-HSCT) is an established treatment for ...
Through the recruitment of immunologic mechanisms, allogeneic hematopoeitic cell transplantation (HC...
Allogenic haematopoietic progenitor cell transplantation (allo-HSCT) is an established treatment for...
Recent investigations have found a higher incidence of adverse events associated with hematopoietic ...
The studies described in this thesis are aimed at improving the whole spectrum of unrelated HSCT in ...
Hematopoietic cell transplantation (HCT) is a highly complex procedure that requires a dedicated mul...
The increasing number of older adults with blood-related disorders and the introduction of reduced i...
We investigated whether a young human leukocyte antigen (HLA)-matched unrelated donor (MUD) should b...
Eligibility criteria for hematopoietic stem cell transplantation (HSCT) in acute lymphoblastic leuke...